Tenecteplase Plus Urinary Kallidinogenase for Acute Ischemic Stroke (TUKIS)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT07283159
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Registry
-
NCT07283159
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07283159. Randomized; quadruple masking; primary purpose treatment. Start 2026-01-20 (actual); primary completion 2027-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tenecteplase Plus Urinary Kallidinogenase for Acute Ischemic Stroke (TUKIS)
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Human Urinary Kallidinogenase
- Lead sponsor
- General Hospital of Shenyang Military Region
Record details
- Record id
cardio:ct-nct07283159- Content hash
8b10a49f5ce46ff46eb521fc232207ff5cad9034e40761abe001e8faec0e6cec